XML 51 R27.htm IDEA: XBRL DOCUMENT v2.4.0.6
Quarterly Financial Information
12 Months Ended
Dec. 31, 2011
Quarterly Financial Information [Abstract]  
Quarterly Financial Information

Note 20. Quarterly Financial Information (Unaudited)

The following tables summarize the Company's quarterly financial information for the years ended December 31, 2011 and 2010 (in thousands except per share amounts):

 

     Three Months Ended  
     March 31,
2011(1)
    June 30,
2011(1)
    September 30,
2011(1)
    December 31,
2011
 

Revenue:

        

Product revenue

   $ 6,183      $ 6,753      $ 7,770      $ 9,896   

Government grants and cooperative agreements

     436        0        1,479        527   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total revenue

     6,619        6,753        9,249        10,423   

Cost of product revenue

     3,529        4,074        4,726        6,206   
  

 

 

   

 

 

   

 

 

   

 

 

 

Gross profit

     3,090        2,679        4,523        4,217   

Operating expenses:

        

Research and development

     1,808        1,994        1,814        1,562   

Selling, general and administrative

     5,528        6,207        5,380        5,938   

Amortization of intangible assets

     50        51        51        50   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total operating expenses

     7,386        8,252        7,245        7,550   
  

 

 

   

 

 

   

 

 

   

 

 

 

Loss from operations

     (4,296     (5,573     (2,722     (3,333

Non-operating income (expense), net

     (802     (836     4,982        (4,402
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income (loss)

   $ (5,098   $ (6,409   $ 2,260      $ (7,735
  

 

 

   

 

 

   

 

 

   

 

 

 

Net loss per common share:

        

Basic

   $ (0.11   $ (0.13   $ 0.05      $ (0.16

Diluted

   $ (0.11   $ (0.13   $ 0.05      $ (0.16

 

 

     Three Months Ended  
     March 31,
2010
    June 30,
2010
    September 30,
2010
    December 31,
2010
 

Revenue:

        

Product revenue

   $ 5,500      $ 5,690      $ 4,521      $ 5,965   

Government grants and cooperative agreements

     222        245        470        496   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total revenue

     5,722        5,935        4,991        6,461   

Cost of product revenue

     3,158        2,934        2,324        3,630   
  

 

 

   

 

 

   

 

 

   

 

 

 

Gross profit

     2,564        3,001        2,667        2,831   

Operating expenses (gains):

        

Research and development

     1,250        1,244        1,282        1,419   

Selling, general and administrative

     5,270        5,304        5,089        5,913   

Amortization of intangible assets

     0        0        0        67   

Acquisition related costs and impairment of long-term investments in related parties, net

     251        132        (201     0   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total operating expenses

     6,771        6,680        6,170        7,399   
  

 

 

   

 

 

   

 

 

   

 

 

 

Loss from operations

     (4,207     (3,679     (3,503     (4,568

Non-operating income (expense), net

     (1,066     (1,880     (128     2,120   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net loss

   $ (5,273   $ (5,559   $ (3,631   $ (2,448
  

 

 

   

 

 

   

 

 

   

 

 

 

Net loss per common share:

        

Basic

   $ (0.14   $ (0.14   $ (0.09   $ (0.06

Diluted

   $ (0.14   $ (0.14   $ (0.09   $ (0.06

(1) The financial information for the first three quarters of 2011 have been restated from amounts previously reported in the Company's quarterly reports on Form 10-Q for cost of product revenue, gross profit, loss from operations, total non-operating income (expense), net, and net loss. The adjustments made related to capitalized inventory costs, which should have been charged to cost of product revenue as products were sold. The Company has determined that although the corrections were immaterial to each of the quarters ended March 31, June 30, and September 30, 2011, the Company has decided to restate the amounts previously reported to better reflect the actual operating trends of the business for 2011. The adjustments primarily impacted the cost of product revenue by $0.1 million for each of the three months ended March 31, 2011, June 30, 2011 and September 30, 2011. In addition, there was no impact to loss per share as a result of these immaterial misstatements in each of the three months ended March 31, 2011, June 30, 2011 and September 30, 2011.